PNPLA3 not only plays a role in increasing the susceptibility to NAFLD, but also is related to abdominal visceral fat accumulation [61], and this gene has been proved to be one of the risk factors for NAFLD in non-obese people [62]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.